Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,750.52
1,935.62
2,064.91
1,955.93
1,599.91
1,412.84
1,307.71
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,750.52
1,935.62
2,064.91
1,955.93
1,599.91
1,412.84
1,307.71
Raw Material Cost
1,297.41
1,475.00
1,531.34
1,511.47
1,158.70
1,062.85
853.05
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
247.21
285.37
305.80
291.69
229.96
172.27
193.76
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
60.09
61.23
55.70
65.77
87.11
75.05
69.12
Selling and Distribution Expenses
258.87
293.19
323.15
337.21
260.96
213.07
297.53
Other Expenses
-24.79
-25.47
-24.39
-24.93
-26.72
-19.06
-21.05
Total Expenditure (Excl Depreciation)
1,615.69
1,860.05
1,972.12
1,956.87
1,469.56
1,332.63
1,202.98
Operating Profit (PBDIT) excl Other Income
134.8
75.6
92.8
-0.8999999999999999
130.29999999999998
80.19999999999999
104.7
Other Income
13.18
14.75
22.84
17.97
15.37
27.70
19.55
Operating Profit (PBDIT)
212.66
161.45
183.22
77.47
166.81
147.18
160.52
Interest
60.09
61.23
55.70
65.77
87.11
75.05
69.12
Exceptional Items
1.40
7.94
-0.53
-20.55
-11.78
2.38
-0.45
Gross Profit (PBDT)
453.11
460.62
533.56
444.46
441.20
349.98
454.66
Depreciation
73.02
73.21
75.69
67.93
60.50
46.42
43.12
Profit Before Tax
80.94
34.94
51.29
-76.78
7.42
28.10
47.84
Tax
11.64
-18.42
-1.87
-7.09
0.67
1.64
4.75
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
60.00
50.53
43.56
-72.20
6.00
29.24
44.41
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
60.00
50.53
43.56
-72.20
6.00
29.24
44.41
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
5.87
2.97
1.27
-3.56
0.78
-1.65
-1.85
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
65.87
53.50
44.83
-75.76
6.78
27.60
42.57
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,604.36
1,574.73
1,578.49
1,570.42
1,660.51
1,453.42
1,375.00
Earnings per share (EPS)
0.11
0.09
0.08
-0.13
0.01
0.05
0.08
Diluted Earnings per share
0.11
0.09
0.08
-0.13
0.01
0.05
0.08
Operating Profit Margin (Excl OI)
7.22%
3.8%
4.1%
-0.43%
5.68%
5.17%
7.48%
Gross Profit Margin
8.8%
5.59%
6.15%
-0.45%
4.24%
5.27%
6.96%
PAT Margin
3.43%
2.61%
2.11%
-3.69%
0.37%
2.07%
3.4%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is -9.56% vs -6.26% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 23.18% vs 19.42% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is 35.99% vs -8.54% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -1.80% vs 9.87% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has improved from Dec 2024
Compare Annual Results Of Henan Taloph Pharmaceutical Stock Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,750.52
0
1,750.52
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,750.52
0
1,750.52
Raw Material Cost
1,297.41
0
1,297.41
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
247.21
0
247.21
Power Cost
0
0
0.00
Manufacturing Expenses
60.09
0
60.09
Selling and Distribution Expenses
258.87
0
258.87
Other Expenses
-24.79
0.00
-24.79
Total Expenditure (Excl Depreciation)
1,615.69
0
1,615.69
Operating Profit (PBDIT) excl Other Income
134.84
0.00
134.84
Other Income
13.18
0
13.18
Operating Profit (PBDIT)
212.66
0
212.66
Interest
60.09
0
60.09
Exceptional Items
1.40
0
1.40
Gross Profit (PBDT)
453.11
0
453.11
Depreciation
73.02
0
73.02
Profit Before Tax
80.94
0
80.94
Tax
11.64
0
11.64
Provisions and contingencies
0
0
0.00
Profit After Tax
60.00
0
60.00
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
60.00
0
60.00
Share in Profit of Associates
0
0
0.00
Minority Interest
5.87
0
5.87
Other related items
0.00
0.00
0.00
Consolidated Net Profit
65.87
0
65.87
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,604.36
0
1,604.36
Earnings per share (EPS)
0.11
0
0.11
Diluted Earnings per share
0.11
0
0.11
Operating Profit Margin (Excl OI)
7.22%
0%
0.00
7.22%
Gross Profit Margin
8.80%
0%
0.00
8.80%
PAT Margin
3.43%
0%
0.00
3.43%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 175.05 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -9.56% vs -6.26% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 6.59 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 23.18% vs 19.42% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 19.95 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 35.99% vs -8.54% in Dec 2024
Annual - Interest
Interest 6.01 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -1.80% vs 9.87% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 7.22%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has improved from Dec 2024






